IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study.

MLA

Kaddu, Mulindwa, Dominic, et al. “IgG Seroprevalence of COVID‐19 among People Living with HIV or at High Risk of HIV in South‐west Germany: A Seroprevalence Study.” HIV Medicine, vol. 23, no. 5, May 2022, pp. 564–69. EBSCOhost, https://doi.org/10.1111/hiv.13207.

APA

Kaddu, M. D., Keuser, L., Lesan, V., Rissland, J., Smola, S., Werdecker, V., Stilgenbauer, S., Christofyllakis, K., Thurner, L., Bewarder, M., Lohr, B., Lutz, J., Lohse, S., & Rieke, A. (2022). IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study. HIV Medicine, 23(5), 564–569. https://doi.org/10.1111/hiv.13207

Chicago

Kaddu, Mulindwa, Dominic, Lukas Keuser, Vadim Lesan, Jürgen Rissland, Sigrun Smola, Victoria Werdecker, Stephan Stilgenbauer, et al. 2022. “IgG Seroprevalence of COVID‐19 among People Living with HIV or at High Risk of HIV in South‐west Germany: A Seroprevalence Study.” HIV Medicine 23 (5): 564–69. doi:10.1111/hiv.13207.